Friday, April 17, 2015

Addressing the Challenges of Non-Adherence

They describe AppaGrapha, a new free mobile app for improving patient adherence to drug therapy. This intriguing app allows patients to monitor their own therapy, provides feedback on adherence, confidentially shares data with a healthcare provider or pharmacist, and more. Details below. Android users can download the free AppaGrapha mobile app here. The iOS version will be available soon.

As pharmacists and consultants, we believe that one of the greatest obstacles facing patients today is the ability to consistently take medication as prescribed, and successfully manage their health.

Currently available compliance solutions—offered through physician, pharmacy, and insurance providers—are channel biased and transactional in nature. They are often disjointed and lead to patient confusion. These solutions revolve around office visits, prescription refills, periodic phone calls, texts, or other activities.

These interventions are convenient for the providers, but frequently occur at times that are inconvenient for the patient. The problem with this approach is that it is isolated, labor intensive, and not patient centric. Despite these various efforts, patient non-adherence remains a $317 billion problem.

Making Patients a Part of the Solution

To address the challenges of patient non-adherence, we at Odin Pharmacy Innovations created AppaGrapha, a patient-centric, intuitive, user-friendly free mobile app. The app allows patients to actively document their adherence, reason for non-adherence, and sense of well-being.

AppaGrapha is designed to help patients successfully integrate their medication and health therapy with a busy life. The ultimate goal is to improve the patient’s health and quality of life via utilization of this app, along with existing Medication Therapy Management (MTM) activities.

[Click to Enlarge]

The AppaGrapha functionality allows for the initiation and persistence of dialogue across the continuum of care. The key interested parties include discharge planners, nurses, pharmacists, and physicians. With AppaGrapha, a practitioner or patient conveniently has the information needed to initiate a one-on-one conversation regarding treatment plans, medication adherence or barriers to success.

AppaGrapha engages and encourages patients to take a prominent role in being healthy and productive. Growing evidence supports that increased medication adherence decreases emergency room visits, hospitalizations, and unnecessary health care costs. (source)

Patients Need AppaGrapha

Patients are aware of health metrics such as BP (120/80), FBS (< 100), A1C (< 5.7), and can frequently recite their numbers. Ask a patient, “How are you at taking your medication?” The response is usually “pretty good,” despite the absence of a concrete method of measurement with which to accurately evaluate adherence.

[Click to Enlarge]

With AppaGrapha patients take an active role in becoming compliant with their treatments, understanding their progress, and reaching their therapeutic goals.

AppaGrapha by design is intuitive, friendly, and simple to use. Our experience as pharmacists interacting with patients guided us in designing the app to be flexible and discreet. AppaGrapha, a comprehensive app, incorporates five patient levels: reminder, feedback, context, summary, and related resources.

Compare against a community of unidentified patients taking the same medication

Built-in motivational tool to beat the average and drive adherence upwards

Summary:

Convenient summary functionality

Summarize medications, allergies, and notes

Generate an organized record of important information

Send via email, text, or print a summary of treatment or dosing history

Facilitate medication reconciliation or updates to health forms

Quickly enter notes and save for future reference

Related Resources:

Locate and view a variety of health centric and patient focused services

Define a desired geographic radius

Recommend resources that would benefit other patients

Look for regularly updated resources based on user recommendations

As you can see, AppaGrapha is more than a simple medication reminder. It is a multi-functional tool designed to provide patients with solutions that can be shared with all members of their health care team.

AppaGrapha improves accuracy and efficiency of admissions processing, medication reconciliation, and discharge planning. It acts as a catalyst for dialogue between patient and clinician.

We at Odin Pharmacy Innovations LLC have been working extensively in the specialty pharmacy space and across the spectrum of pharmacy channels. Please contact us to discuss opportunities to improve patient outcomes via AppaGrapha and our other designed offerings.

Developing solutions via innovative processes is what Odin does best. We look forward to helping you drive improvement and deliver results. We will be at the Armada Specialty Pharmacy Summit in May. Please visit us at booth #326.

Your journey to breakthrough discoveries starts with Odin. Let’s get to work.

DISCLAIMERThe analyses on this website are based on information and data that are in the public domain. Any conclusions, findings, opinions, or recommendations are based on our own experienced and professional judgment and interpretations given the information available. While all information is believed to be reliable at the time of writing, the information provided here is for reference use only and does not constitute the rendering of legal, financial, commercial, or other professional advice by Pembroke Consulting, Inc., Drug Channels Institute, or the author. Any reliance upon the information is at your own risk, and Pembroke Consulting, Inc., Drug Channels Institute, and the author shall not be responsible for any liability arising from or related to the use or accuracy of the information in any way. Pembroke Consulting, Inc., and Drug Channels Institute do not make investment recommendations, on this website or otherwise. Nothing on this website should be interpreted as an opinion by Pembroke Consulting, Inc., Drug Channels Institute, or the author on the investment prospects of specific companies.

The comments contained on this site come from members of the public and do not necessarily reflect the views of Drug Channels Institute or the author. Neither Drug Channels Institute nor the author endorse or approve of their content. Drug Channels Institute and the author reserve the right to remove or block comments, but are under no obligation to explain individual moderation decisions.

The public domain use of our materials includes linking to our website. You do not need to obtain special permission to link to the Drug Channels site. The material on this site is protected by copyright law. Unauthorized reproduction or distribution of this material may result in severe civil and criminal penalties and will be prosecuted to the maximum extent of the law. This report may be cited in commercial documents with full and appropriate attribution. We do not intend to reduce, limit, or restrict any rights arising from fair use under copyright law or other applicable laws. We do not permit our articles to be republished without prior written permission.

The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels Institute, or any of its employees.